Institutional Ownership Eton Pharmaceuticals, Inc. (ETON)
This table provides information about the institutional ownership of Eton Pharmaceuticals, Inc. (ETON). We have compiled data on the 85 institutions that hold shares in the stock, with a total of 15 Million shares, which have been reported (via 13F filing form) to have a value of $259 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Opaleye Management Inc.
Boston, MA |
Aug 15, 2025 Q2 2025 |
2,860,000
shares
|
$49.5 Million
9.75% of portfolio
|
Q2 2025
Added 0.28%
|
|
|
Eco R1 Capital, LLC
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
2,030,544
shares
|
$35.2 Million
2.49% of portfolio
|
Q2 2025
Added 4.71%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
1,312,173
shares
|
$22.7 Million
0.0% of portfolio
|
Q2 2025
Added 19.18%
|
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
Aug 14, 2025 Q2 2025 |
1,175,951
shares
|
$20.4 Million
0.73% of portfolio
|
Q1 2025
Added 5.14%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
592,865
shares
|
$10.3 Million
0.0% of portfolio
|
Q2 2025
Added 98.78%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
509,568
shares
|
$8.83 Million
0.0% of portfolio
|
Q2 2025
Added 245.86%
|
|
|
Divisadero Street Capital Management, LP
Miami, FL |
Aug 13, 2025 Q2 2025 |
497,716
shares
|
$8.62 Million
0.64% of portfolio
|
Q2 2025
New holding
|
|
|
Westside Investment Management, Inc.
|
Aug 05, 2025 Q2 2025 |
472,790
shares
|
$8.19 Million
1.25% of portfolio
|
Q2 2025
Reduced 4.23%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
405,900
shares
|
$7.03 Million
0.01% of portfolio
|
Q2 2025
Added 48.14%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Aug 07, 2025 Q2 2025 |
392,715
shares
|
$6.8 Million
0.01% of portfolio
|
Q2 2025
Reduced 2.41%
|
|
|
Cannell Capital LLC
Alta, WY |
Aug 14, 2025 Q2 2025 |
388,175
shares
|
$6.72 Million
1.84% of portfolio
|
Q2 2025
Reduced 43.85%
|
|
|
Thompson Siegel & Walmsley LLC
|
Aug 06, 2025 Q2 2025 |
381,265
shares
|
$6.6 Million
0.09% of portfolio
|
Q2 2025
Added 100.81%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
323,194
shares
|
$5.6 Million
0.0% of portfolio
|
Q2 2025
Added 182.92%
|
|
|
Soleus Capital Management, L.P.
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
285,000
shares
|
$4.94 Million
0.31% of portfolio
|
Q2 2025
New holding
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
282,389
shares
|
$4.89 Million
0.0% of portfolio
|
Q2 2024
Reduced 0.2%
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
262,211
shares
|
$4.54 Million
0.0% of portfolio
|
Q2 2025
Added 210.49%
|
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Aug 07, 2025 Q2 2025 |
222,083
shares
|
$3.85 Million
0.01% of portfolio
|
Q2 2025
Reduced 4.49%
|
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
214,552
shares
|
$3.72 Million
0.01% of portfolio
|
Q2 2025
Added 160.52%
|
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
212,484
shares
|
$3.68 Million
0.0% of portfolio
|
Q2 2025
Added 121.92%
|
|
|
Aristides Capital LLC
Ottawa Hills, OH |
Aug 13, 2025 Q2 2025 |
167,587
shares
|
$2.9 Million
0.93% of portfolio
|
Q2 2025
Reduced 30.63%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Aug 14, 2025 Q2 2025 |
135,270
shares
|
$2.34 Million
0.05% of portfolio
|
Q1 2025
Reduced 43.39%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
113,113
shares
|
$1.96 Million
0.0% of portfolio
|
Q1 2025
Added 117.69%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
109,379
shares
|
$1.89 Million
0.0% of portfolio
|
Q2 2025
Reduced 37.58%
|
|
|
Stifel Financial Corp
St. Louis, MO |
Aug 14, 2025 Q2 2025 |
108,168
shares
|
$1.87 Million
0.0% of portfolio
|
Q2 2025
Reduced 66.2%
|
|
|
Apis Capital Advisors, LLC
New York, NY |
Aug 13, 2025 Q2 2025 |
106,000
shares
|
$1.84 Million
0.75% of portfolio
|
Q2 2025
New holding
|